GUFICBIONSEGufic Biosciences Limited· PharmaceuticalsMediumNeutral
Announced Wed, 20 Aug · 17:32 IST

Gufic Biosciences Limited has informed the Exchange about Written Transcript of Earnings Conference Call

Investor Communications View source PDF

GUFICBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Gufic Biosciences has informed the stock exchanges that the written transcript of its earnings conference call held on August 14, 2025 at 12:00 p.m. has been uploaded on the company's website. This filing is made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements, as a follow-up to the company's earlier intimation about the call. The transcript can be accessed via the link provided in the filing. No new financial figures, business updates, or management commentary are included in this particular filing itself — those details would be in the linked transcript document.

Likely market impact

This is a routine procedural disclosure and is unlikely to have any direct impact on the stock price. Investors interested in management's views on performance and outlook should review the actual transcript for any meaningful signals.